Courier Therapeutics
www.couriertherapeutics.comCourier Therapeutics is a biotechnology startup with a cytotoxic-lymphocyte targeting therapy platform, with a focus on making cancer-immunotherapy safer and more efficacious. Courier's first application of this targeting technology technology, CT101, is a first-in-class IL2R agonist which specifically activates the NK and CD8 T cells against cancer.
Read more
Courier Therapeutics is a biotechnology startup with a cytotoxic-lymphocyte targeting therapy platform, with a focus on making cancer-immunotherapy safer and more efficacious. Courier's first application of this targeting technology technology, CT101, is a first-in-class IL2R agonist which specifically activates the NK and CD8 T cells against cancer.
Read more
Country
State
Texas
City (Headquarters)
Houston
Industry
Employees
1-10
Founded
2015
Social
Employees statistics
View all employeesPotential Decision Makers
Founder and Board Member
Email ****** @****.comPhone (***) ****-****
Technologies
(9)
Reach decision makers at Courier Therapeutics
Free credits every month!
Courier Therapeutics FAQ
Houston, United States
Biotechnology Research
